Month: November 2023

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year

Staff November 20, 2023

Allschwil, Switzerland, November 20, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs...

Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema

Staff November 20, 2023

Regulated information – Inside information Despite Prior Positive Data, THR-149 Did Not Demonstrate Improvement in Vision Oxurion’s Board has...

MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

Staff November 20, 2023

LA JOLLA, Calif., Nov. 19, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...

Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000

Staff November 20, 2023

KELOWNA, BC / ACCESSWIRE / November 20, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage biotechnology...

Third Party Withdraws Appeal Related to Cantargia Patent

Staff November 20, 2023

LUND, SE / ACCESSWIRE / November 20, 2023 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported that...

BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis Treament

Staff November 20, 2023

VANCOUVER, BC / ACCESSWIRE / November 20, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...

IRLAB to present at Redeye Life Science Day on November 23, 2023

Staff November 20, 2023

GOTHENBURG, SE / ACCESSWIRE / November 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 20, 2023 - IRLAB Therapeutics...

IRLAB to Present at ABGSC Investor Days on November 22, 2023

Staff November 20, 2023

GOTHENBURG, SE / ACCESSWIRE / November 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 20, 2023 - IRLAB Therapeutics...

Canada’s First Egg Bank Launches, Recruiting Ethnically Diverse Donors for Enhanced Donor Conceived Outcomes

Staff November 18, 2023

Canada's First Egg Bank Launches, in Toronto, Ontario, CanadaTORONTO, ON / ACCESSWIRE / November 18, 2023 / Egg Bank Canada...

Applied UV Announces Third Quarter 2023 Financial Results, Revenue Increases to $11.4 Million, Adjusted EBITDA (non-GAAP) Improves 30.8% Year Over Year

Staff November 18, 2023

NEW YORK, NY, Nov. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ: AUVI), a leader in...

Aurora Spine Grants Stock Options

Staff November 18, 2023

Carlsbad, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a...

Khiron Life Sciences Announces Closing of the Sale of Its European Business

Staff November 17, 2023

Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) ("Khiron" or the "Company") is...

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use

Staff November 17, 2023

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter...

MedTech Innovator Crowns MicroTransponder and Mirai Medical Among its Top Innovators of 2023

Staff November 17, 2023

Revolutionary Medical Device Companies Awarded with Prestigious Mid-Stage Grand Prize and Value Award at the MedTech Strategist Innovation SummitLOS ANGELES--(BUSINESS...

Brüush Receives Nasdaq Notification Regarding Minimum Bid Requirements

Staff November 17, 2023

VANCOUVER, BC / ACCESSWIRE / November 17, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it...

Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

Staff November 17, 2023

TORONTO, ON / ACCESSWIRE / November 17, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...

Cozeva Empowers California Healthcare Organizations as a Qualified Health Information Organization (QHIO) to Navigate Data Exchange Framework (DxF)

Staff November 17, 2023

SAN FRANCISCO, CA / ACCESSWIRE / November 17, 2023 / Cozeva, a pioneer in healthcare technology, announces its official designation...

Among Migrating Nurses, Survey Shows Substantially Higher Satisfaction Rates for Those Who Use a Certified Ethical Recruiter

Staff November 17, 2023

CGFNS International joins with The DAISY Foundation™ to honor outstanding nurse recruitersPHILADELPHIA, PA / ACCESSWIRE / November 17, 2023 /...

University of Wisconsin–Madison and GE HealthCare Broaden Shared Commitment to Healthcare Innovation

Staff November 17, 2023

The 10-year strategic collaboration builds on strong research foundations in medical imaging and expands the scope to advance the delivery...

Solstice Southwest Brings DFW Texas Residential Mental Healthcare

Staff November 17, 2023

Solstice Southwest LLC Awarded Behavioral Health Care and Human Services Accreditation from The Joint CommissionIRVING, TX / ACCESSWIRE / November...

Month: November 2023

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year

Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema

MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000

Third Party Withdraws Appeal Related to Cantargia Patent

BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis Treament

IRLAB to present at Redeye Life Science Day on November 23, 2023

IRLAB to Present at ABGSC Investor Days on November 22, 2023

Canada’s First Egg Bank Launches, Recruiting Ethnically Diverse Donors for Enhanced Donor Conceived Outcomes

Applied UV Announces Third Quarter 2023 Financial Results, Revenue Increases to $11.4 Million, Adjusted EBITDA (non-GAAP) Improves 30.8% Year Over Year

Aurora Spine Grants Stock Options

Khiron Life Sciences Announces Closing of the Sale of Its European Business

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use

MedTech Innovator Crowns MicroTransponder and Mirai Medical Among its Top Innovators of 2023

Brüush Receives Nasdaq Notification Regarding Minimum Bid Requirements

Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

Cozeva Empowers California Healthcare Organizations as a Qualified Health Information Organization (QHIO) to Navigate Data Exchange Framework (DxF)

Among Migrating Nurses, Survey Shows Substantially Higher Satisfaction Rates for Those Who Use a Certified Ethical Recruiter

University of Wisconsin–Madison and GE HealthCare Broaden Shared Commitment to Healthcare Innovation

Solstice Southwest Brings DFW Texas Residential Mental Healthcare

MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users

AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

You may have missed